Home/Filings/4/0001123292-07-000548
4//SEC Filing

Machielse Bernardus N M 4

Accession 0001123292-07-000548

CIK 0000873591other

Filed

Jun 18, 8:00 PM ET

Accepted

Jun 19, 5:31 PM ET

Size

27.6 KB

Accession

0001123292-07-000548

Insider Transaction Report

Form 4
Period: 2007-06-18
Machielse Bernardus N M
Senior VP Operations
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2007-06-1824,0000 total
    Exercise: $41.41Exp: 2012-02-21Common Stock (24,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2007-06-1850,0000 total
    Exercise: $23.45Exp: 2014-03-04Common Stock (50,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2007-06-1820,0000 total
    Exercise: $24.09Exp: 2015-01-26Common Stock (20,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2007-06-1870,0000 total
    Exercise: $36.78Exp: 2016-02-22Common Stock (70,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2007-06-1830,0000 total
    Exercise: $29.34Exp: 2013-02-20Common Stock (30,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2007-06-1822,5000 total
    Exercise: $38.68Exp: 2011-02-15Common Stock (22,500 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2007-06-1875,0000 total
    Exercise: $24.17Exp: 2015-02-15Common Stock (75,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2007-06-1865,0000 total
    Exercise: $31.25Exp: 2017-02-14Common Stock (65,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2007-06-1815,0000 total
    Exercise: $34.70Exp: 2013-09-01Common Stock (15,000 underlying)
Footnotes (10)
  • [F1]This option, which provided for vesting in equal quarterly installments beginning 05/15/2001, was cancelled pursuant to the merger agreement between the issuer and AstraZeneca PLC in exchange for a cash payment of $19.32 per share, representing the difference between the exercise price of the option and $58.00 per share.
  • [F10]This option, which provided for vesting in equal quarterly installments beginning 05/15/2007, was cancelled in the merger in exchange for a cash payment of $26.75 per share, representing the difference between the exercise price of the option and $58.00 per share.
  • [F2]This option, which provided for vesting in equal quarterly installments beginning 05/21/2002, was cancelled in the merger in exchange for a cash payment of $16.59 per share, representing the difference between the exercise price of the option and $58.00 per share.
  • [F3]This option, which provided for vesting in equal quarterly installments beginning 05/20/2003, was cancelled in the merger in exchange for a cash payment of $28.66 per share, representing the difference between the exercise price of the option and $58.00 per share.
  • [F4]This option, which provided for vesting in equal quarterly installments beginning 12/01/2003, was cancelled in the merger in exchange for a cash payment of $23.30 per share, representing the difference between the exercise price of the option and $58.00 per share.
  • [F5]This option, which provided for vesting in equal quarterly installments beginning 06/04/2004, was cancelled in the merger in exchange for a cash payment of $34.55 per share, representing the difference between the exercise price of the option and $58.00 per share.
  • [F6]This option, which provided for vesting in equal quarterly installments beginning 04/27/2005, was cancelled in the merger in exchange for a cash payment of $33.91 per share, representing the difference between the exercise price of the option and $58.00 per share.
  • [F7]This option, which provided for vesting in equal quarterly installments beginning 05/16/2005, was cancelled in the merger in exchange for a cash payment of $33.83 per share, representing the difference between the exercise price of the option and $58.00 per share.
  • [F8]This option, which provided for vesting in equal quarterly installments beginning 05/23/2006, was cancelled in the merger in exchange for a cash payment of $21.22 per share, representing the difference between the exercise price of the option and $58.00 per share.
  • [F9]This option, which provided for vesting in equal quarterly installments beginning 02/08/2007, was cancelled in the merger in exchange for a cash payment of $24.57 per share, representing the difference between the exercise price of the option and $58.00 per share.

Issuer

MEDIMMUNE INC /DE

CIK 0000873591

Entity typeother

Related Parties

1
  • filerCIK 0001315038

Filing Metadata

Form type
4
Filed
Jun 18, 8:00 PM ET
Accepted
Jun 19, 5:31 PM ET
Size
27.6 KB